Cutaneous allergy to human (recombinant DNA) insulin.
p6 report two cases of cutaneous allergy to human (recombinant DNA) insulin. Each patient had a history of systemic allergic reactions to porcine insulin and was at least as reactive to human as to porcine insulin by end-point cutaneous titration. Both patients' insulin allergy was managed with animal insulins and both have done well. Our experience with these two patients indicates that human insulin (rDNA) should not be expected to be efficacious in all patients with systemic allergy to insulin.
D000328:Adult; D000368:Aged; D004274:DNA, Recombinant; D003876:Dermatitis, Atopic / Q000139:chemically induced*; D003920:Diabetes Mellitus / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000009:adverse effects*; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D014581:Urticaria / Q000139:chemically induced
D004274:DNA, Recombinant; D007328:Insulin